Type
. Multidrug therapy in leprosy. Journal of the Indian Medical Association. 2006;104(12):686-8.
Type
. Disability prevention and medical rehabilitation (DPMR)--prevention of disability and timely referral in leprosy. Journal of the Indian Medical Association. 2006;104(12):682-5.
Type
. Diagnosis of leprosy. Journal of the Indian Medical Association. 2006;104(12):680-1, 685.
Type
. Clinical diagnosis of leprosy cases. Journal of the Indian Medical Association. 2006;104(12):676-9.
Type
. Experience of involvement of IMA members in leprosy elimination after CME conducted during 2004-2005. Journal of the Indian Medical Association. 2006;104(12):675.
Type
. NLEP--current situation and strategy during the 11th plan period (2007-2012). Journal of the Indian Medical Association. 2006;104(12):671-2.
Type
. International Federation of Antileprosy Associations and National Leprosy Eradication Programme--an alliance that accelerated quality leprosy services. Journal of the Indian Medical Association. 2006;104(12):669-70.
Type
. [Contributions of the Netherlands and its colonies to the knowledge of the cause of leprosy in the 19th century]. Nederlands tijdschrift voor geneeskunde [Internet]. 2007;151(14):825-30. Available from: http://www.ntvg.nl/publicatie/bijdragen-van-nederland-en-zijn-koloni%C3%ABn-aan-de-kennis-over-de-oorzaak-van-lepra-de-19e-e/volledig
Type
. The proteasome function is required for Mycobacterium leprae-induced apoptosis and cytokine secretion. Immunology letters. 2007;110(1):82-5.
Type
. Protective effect of bacillus Calmette Guerin (BCG) vaccine in the prevention of leprosy: a meta-analysis. Indian journal of dermatology, venereology and leprology [Internet]. 2007;73(2):86-93. Available from: http://www.ijdvl.com/article.asp?issn=0378-6323;year=2007;volume=73;issue=2;spage=86;epage=93;aulast=Zodpey